Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Christophe

Showing results (121-130 of 149) with videos related to

Pageof 15
Sort By:
Bioinformatics (Oxford, England)|November 1, 2016
Network-based analysis of omics data: the LEAN methodFrederik Gwinner, Gwénola Boulday, Claire Vandiedonck, et al.
Thrombosis and Haemostasis|June 30, 2026
Anti-TFPI Single-Domain Antibodies: Novel Rebalancing Therapies for Hemophilia and Other Rare Bleeding DisordersClaire Auditeau, Elsa P Bianchini, Ivan Peyron, et al.
Blood|September 4, 2025
A bispecific nanobody for the treatment of von Willebrand disease type 1Ivan Peyron, Caterina Casari, Genevieve McCluskey, et al.
Haematologica|November 28, 2024
A fully humanized von Willebrand disease type 1 mouse model as unique platform to investigate novel therapeutic optionsGenevieve McCluskey, Marco Heestermans, Ivan Peyron, et al.
The Journal of Clinical Investigation|November 26, 2013
von Willebrand factor mutation promotes thrombocytopathy by inhibiting integrin αIIbβ3Caterina Casari, Eliane Berrou, Marilyne Lebret, et al.
Blood|January 12, 2012
Macrophage LRP1 contributes to the clearance of von Willebrand factorGhasem Rastegarlari, Julie N Pegon, Caterina Casari, et al.
Nature Communications|August 14, 2023
Toll-like receptor 4 and macrophage scavenger receptor 1 crosstalk regulates phagocytosis of a fungal pathogenChinaemerem U Onyishi, Guillaume E Desanti, Alex L Wilkinson, et al.
Blood|January 22, 2013
Mutations in the A3 domain of von Willebrand factor inducing combined qualitative and quantitative defects in the proteinPaulette Legendre, Ana-Maria Navarrete, Julie Rayes, et al.
Plos One|December 10, 2015
Apoptotic Platelet Events Are Not Observed in Severe von Willebrand Disease-Type 2B Mutation p.V1316MEliane Berrou, Alexandre Kauskot, Frédéric Adam, et al.
Haematologica|December 1, 2025
<i>Erratum</i> to: "Consistent clinical factor VIII equivalency is unlikely for non-factor therapies in hemophilic mice"Thibaud Sefiane, Geneviève McCluskey, Marie Clavel, et al.
Pageof 15

Showing results (121-130 of 149) with videos related to

Sort By:
Pageof 15
Bioinformatics (Oxford, England)|November 1, 2016
Network-based analysis of omics data: the LEAN methodFrederik Gwinner, Gwénola Boulday, Claire Vandiedonck, et al.
Thrombosis and Haemostasis|June 30, 2026
Anti-TFPI Single-Domain Antibodies: Novel Rebalancing Therapies for Hemophilia and Other Rare Bleeding DisordersClaire Auditeau, Elsa P Bianchini, Ivan Peyron, et al.
Blood|September 4, 2025
A bispecific nanobody for the treatment of von Willebrand disease type 1Ivan Peyron, Caterina Casari, Genevieve McCluskey, et al.
Haematologica|November 28, 2024
A fully humanized von Willebrand disease type 1 mouse model as unique platform to investigate novel therapeutic optionsGenevieve McCluskey, Marco Heestermans, Ivan Peyron, et al.
The Journal of Clinical Investigation|November 26, 2013
von Willebrand factor mutation promotes thrombocytopathy by inhibiting integrin αIIbβ3Caterina Casari, Eliane Berrou, Marilyne Lebret, et al.
Blood|January 12, 2012
Macrophage LRP1 contributes to the clearance of von Willebrand factorGhasem Rastegarlari, Julie N Pegon, Caterina Casari, et al.
Nature Communications|August 14, 2023
Toll-like receptor 4 and macrophage scavenger receptor 1 crosstalk regulates phagocytosis of a fungal pathogenChinaemerem U Onyishi, Guillaume E Desanti, Alex L Wilkinson, et al.
Blood|January 22, 2013
Mutations in the A3 domain of von Willebrand factor inducing combined qualitative and quantitative defects in the proteinPaulette Legendre, Ana-Maria Navarrete, Julie Rayes, et al.
Plos One|December 10, 2015
Apoptotic Platelet Events Are Not Observed in Severe von Willebrand Disease-Type 2B Mutation p.V1316MEliane Berrou, Alexandre Kauskot, Frédéric Adam, et al.
Haematologica|December 1, 2025
<i>Erratum</i> to: "Consistent clinical factor VIII equivalency is unlikely for non-factor therapies in hemophilic mice"Thibaud Sefiane, Geneviève McCluskey, Marie Clavel, et al.
Pageof 15